Neuroscience

MS relapse risk not increased in postoperative period

(HealthDay)—Exposure to a surgical procedure requiring anesthesia does not seem to increase the risk for postoperative multiple sclerosis (MS) relapse, according to a study published online June 25 in the Multiple Sclerosis ...

Medications

FDA approves mavenclad for treating multiple sclerosis

(HealthDay)—Mavenclad (cladribine) tablets were approved to treat adult patients with relapsing-remitting and active secondary progressive multiple sclerosis (MS) who have inadequately responded to or cannot tolerate an ...

Neuroscience

How the brain fights off fears that return to haunt us

Neuroscientists at The University of Texas at Austin have discovered a group of cells in the brain that are responsible when a frightening memory re-emerges unexpectedly, like Michael Myers in every "Halloween" movie. The ...

Oncology & Cancer

An epigenetic marker can predict survival in childhood leukaemia

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...

Medications

Combination therapy might be beneficial in schizophrenia

Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. This is suggested in a paper published by researchers at ...

page 1 from 23